Abbott Laboratories (DE:ABL)
XETRA:ABL
Holding DE:ABL?
Track your performance easily

Abbott Laboratories (ABL) Financial Statements

6 Followers

Abbott Laboratories Financial Overview

Abbott Laboratories's market cap is currently ―. The company's EPS TTM is €2.93; its P/E ratio is 34.87; and it has a dividend yield of 1.91%. Abbott Laboratories is scheduled to report earnings on October 16, 2024, and the estimated EPS forecast is €1.09. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 10.38B$ 9.96B$ 10.24B$ 10.14B$ 9.98B
Gross Profit$ 5.77B$ 5.50B$ 5.68B$ 5.54B$ 5.50B
EBIT$ 1.75B$ 1.58B$ 1.95B$ 1.84B$ 1.79B
EBITDA$ 2.55B$ 2.38B$ 2.77B$ 2.66B$ 2.60B
Net Income Common Stockholders$ 1.30B$ 1.23B$ 1.59B$ 1.44B$ 1.38B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.22B$ 6.65B$ 7.28B$ 7.05B$ 8.15B
Total Assets$ 73.02B$ 72.47B$ 73.21B$ 72.09B$ 73.40B
Total Debt$ 14.75B$ 14.59B$ 14.68B$ 15.53B$ 16.85B
Net Debt$ 7.54B$ 7.93B$ 7.40B$ 8.48B$ 8.69B
Total Liabilities$ 33.46B$ 33.42B$ 34.39B$ 34.40B$ 35.95B
Stockholders Equity$ 39.32B$ 38.81B$ 38.60B$ 37.48B$ 37.17B
Cash Flow-
Free Cash Flow$ 1.43B$ 627.00M$ 2.28B$ 1.32B$ 696.00M
Operating Cash Flow$ 1.96B$ 1.02B$ 3.04B$ 1.88B$ 1.20B
Investing Cash Flow$ -453.00M$ -425.00M$ -824.00M$ -634.00M$ -1.21B
Financing Cash Flow$ -791.00M$ -1.18B$ -2.05B$ -2.34B$ -1.29B
Currency in USD

Abbott Laboratories Earnings and Revenue History

Abbott Laboratories Debt to Assets

Abbott Laboratories Cash Flow

Abbott Laboratories Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis